Hepatitis in the elderly: still a scourge

Area of Science:

• Hepatology
• Infectious Diseases
• Geriatric Medicine

Background:

• Liver disease, often caused by viral hepatitis, manifests with symptoms like fatigue, jaundice, and anorexia.
• Hepatotropic viruses (Hepatitis A, B, C, D, E) are the primary cause, with differing transmission and treatment options.
• Older adults (over 65) are at higher risk for severe hepatitis outcomes.

Purpose of the Study:

• To summarize the clinical presentation, causes, and management of various viral hepatitis types.
• To highlight the challenges in treating hepatitis, particularly in the elderly population.
• To emphasize the critical role of pharmacists in managing hepatitis patients.

Main Methods:

• Review of clinical presentations and etiological factors of viral hepatitis.
• Analysis of current treatment modalities and their limitations for different hepatitis types.
• Discussion of age-related disease severity and comorbidity considerations.

Main Results:

• Hepatitis A is typically self-limiting; Hepatitis B has FDA-approved treatments but potential elderly comorbidities.
• Hepatitis C treatment involves interferon and ribavirin; Hepatitis D is aggressive, often leading to cirrhosis.
• Hepatitis E is poorly understood and sporadically reported in the US.

Conclusions:

• Management of viral hepatitis is complex, costly, and requires complete patient adherence.
• Pharmacist consultation is crucial for optimizing patient care, especially with new agents and potential side effects.
• Education and support for patients, families, and staff are essential for successful treatment outcomes.